Optimisation and evaluation of the random forest model in the efficacy prediction of chemoradiotherapy for advanced cervical cancer based on radiomics signature from high-resolution T2 weighted images.
Cervical cancer
Chemoradiotherapy
Radiomics
Random forest
T2-weighted image
Journal
Archives of gynecology and obstetrics
ISSN: 1432-0711
Titre abrégé: Arch Gynecol Obstet
Pays: Germany
ID NLM: 8710213
Informations de publication
Date de publication:
03 2021
03 2021
Historique:
received:
20
08
2020
accepted:
17
11
2020
pubmed:
5
1
2021
medline:
1
4
2021
entrez:
4
1
2021
Statut:
ppublish
Résumé
Our objective was to establish a random forest model and to evaluate its predictive capability of the treatment effect of neoadjuvant chemotherapy-radiation therapy. This retrospective study included 82 patients with locally advanced cervical cancer who underwent scanning from March 2013 to May 2018. The random forest model was established and optimised based on the open source toolkit scikit-learn. Byoptimising of the number of decision trees in the random forest, the criteria for selecting the final partition index and the minimum number of samples partitioned by each node, the performance of random forest in the prediction of the treatment effect of neoadjuvant chemotherapy-radiation therapy on advanced cervical cancer (> IIb) was evaluated. The number of decision trees in the random forests influenced the model performance. When the number of decision trees was set to 10, 25, 40, 55, 70, 85 and 100, the performance of random forest model exhibited an increasing trend first and then a decreasing one. The criteria for the selection of final partition index showed significant effects on the generation of decision trees. The Gini index demonstrated a better effect compared with information gain index. The area under the receiver operating curve for Gini index attained a value of 0.917. The random forest model showed potential in predicting the treatment effect of neoadjuvant chemotherapy-radiation therapy based on high-resolution T2WIs for advanced cervical cancer (> IIb).
Identifiants
pubmed: 33394142
doi: 10.1007/s00404-020-05908-5
pii: 10.1007/s00404-020-05908-5
pmc: PMC7960581
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
811-820Références
J Magn Reson Imaging. 2020 Dec;52(6):1859-1869
pubmed: 32798294
Insights Imaging. 2012 Dec;3(6):573-89
pubmed: 23093486
Radiology. 2016 Feb;278(2):563-77
pubmed: 26579733
Eur J Radiol. 2020 Oct;131:109214
pubmed: 32835853
CA Cancer J Clin. 2015 Jan-Feb;65(1):5-29
pubmed: 25559415
Biomed Res Int. 2020 Aug 08;2020:3929435
pubmed: 32851067
Cancer Causes Control. 2019 Nov;30(11):1183-1200
pubmed: 31471762
Front Oncol. 2020 May 05;10:563
pubmed: 32432035
Chang Gung Med J. 2011 Jan-Feb;34(1):93-100
pubmed: 21392479
J Med Imaging Radiat Oncol. 2020 Dec;64(6):873-881
pubmed: 32978901
Eur Radiol. 2021 Apr;31(4):2368-2376
pubmed: 33033863
Gigascience. 2018 Feb 1;7(2):
pubmed: 29267859
Sensors (Basel). 2020 Oct 22;20(21):
pubmed: 33105712
Annu Int Conf IEEE Eng Med Biol Soc. 2020 Jul;2020:1667-1670
pubmed: 33018316
Arch Gynecol Obstet. 2014 Dec;290(6):1201-5
pubmed: 25001571
Front Oncol. 2020 Aug 20;10:1393
pubmed: 32974143
Gynecol Oncol. 2015 Mar;136(3):534-41
pubmed: 25575481
Arch Gynecol Obstet. 2019 Feb;299(2):299-315
pubmed: 30542793
J Contemp Brachytherapy. 2019 Feb;11(1):41-47
pubmed: 30911309
J BUON. 2020 Jan-Feb;25(1):108-115
pubmed: 32277621
Acta Oncol. 2015;54(9):1423-9
pubmed: 26264429
J Am Stat Assoc. 2015;110(512):1770-1784
pubmed: 26903687
Eur J Cancer. 2012 Mar;48(4):441-6
pubmed: 22257792
Eur J Radiol. 2020 Oct;131:109219
pubmed: 32905953
Crit Rev Oncol Hematol. 2020 Aug;152:102985
pubmed: 32497972
Eur Radiol. 2020 Jun;30(6):3585-3593
pubmed: 32065284
Abdom Radiol (NY). 2022 Sep;47(9):3078-3100
pubmed: 33095312
Phys Med. 2017 Jun;38:122-139
pubmed: 28595812
Phys Med Biol. 2021 Jan 26;66(3):035015
pubmed: 33032267
Radiother Oncol. 2019 Sep;138:141-148
pubmed: 31252296
Front Oncol. 2020 Apr 15;10:464
pubmed: 32373511
J Oncol. 2019 Dec 26;2019:4731532
pubmed: 31949430
Oncotarget. 2018 Dec 14;9(98):37125-37136
pubmed: 30647849
J Magn Reson Imaging. 2021 Apr;53(4):1054-1065
pubmed: 33037745
Curr Oncol Rep. 2019 Jul 29;21(9):77
pubmed: 31359169
Front Oncol. 2020 Jul 17;10:1042
pubmed: 32766134
Proc Natl Acad Sci U S A. 2018 Feb 20;115(8):1943-1948
pubmed: 29351989
Int J Gynaecol Obstet. 2019 Apr;145(1):129-135
pubmed: 30656645